<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药春秋 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-10T23:32:59+08:00</updated>
  <subtitle>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>抗抑郁潜力大赛道，本土企业早已加速冲线！</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/4xZ51qdOD1s3gQChauL-ig</id>
    <link href="https://mp.weixin.qq.com/s/4xZ51qdOD1s3gQChauL-ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>5个国采未中选药调整价格</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/1uHYoIOvfikJC84zTVBJ6Q</id>
    <link href="https://mp.weixin.qq.com/s/1uHYoIOvfikJC84zTVBJ6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>官宣！两款临床常用药转OTC</title>
    <updated>2020-12-10T21:50:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/3qcTOy63MQ-NXFChZNa82w</id>
    <link href="https://mp.weixin.qq.com/s/3qcTOy63MQ-NXFChZNa82w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专利期满，国内仿制闻风而至，重磅西那卡塞能否再创佳绩？</title>
    <updated>2020-12-09T21:47:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Gqu11vOlIErKSvL_uawW7Q</id>
    <link href="https://mp.weixin.qq.com/s/Gqu11vOlIErKSvL_uawW7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>集采扩容续约开始，各地情况不同！</title>
    <updated>2020-12-09T21:47:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/TmANOvUd5y0CezFPEnVfwg</id>
    <link href="https://mp.weixin.qq.com/s/TmANOvUd5y0CezFPEnVfwg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>43个药品价格下调，涉及阿卡波糖、丁苯酞、阿奇霉素...</title>
    <updated>2020-12-09T21:47:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/WWM2bUHaQPYfGHaMp-3ZeQ</id>
    <link href="https://mp.weixin.qq.com/s/WWM2bUHaQPYfGHaMp-3ZeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>（2020.12.8）最新过评清单；35品规在列，7品种首家</title>
    <updated>2020-12-08T21:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/uWBr3L3um0keyiIQXl6Xlw</id>
    <link href="https://mp.weixin.qq.com/s/uWBr3L3um0keyiIQXl6Xlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一大批药品降价、暂停交易！</title>
    <updated>2020-12-08T21:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/eFoI5jXN9t6R7DE1HBKEYA</id>
    <link href="https://mp.weixin.qq.com/s/eFoI5jXN9t6R7DE1HBKEYA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>注意！20个自费药超过最低价</title>
    <updated>2020-12-08T21:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/A-gwSYYYImXd4L4MuOZShQ</id>
    <link href="https://mp.weixin.qq.com/s/A-gwSYYYImXd4L4MuOZShQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020国家医保谈判，这些重点可提前捕获！</title>
    <updated>2020-12-08T21:36:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-08:/s/WjhdbQ6oQ8LYl1rILvtWjg</id>
    <link href="https://mp.weixin.qq.com/s/WjhdbQ6oQ8LYl1rILvtWjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新一轮国采，注射剂大热！过评、申报走势如何？</title>
    <updated>2020-12-07T21:39:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/inxhxAed9xVyix_AuIVkgQ</id>
    <link href="https://mp.weixin.qq.com/s/inxhxAed9xVyix_AuIVkgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>所有药品，联动全国「最低价」</title>
    <updated>2020-12-07T21:39:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/Q9QiK7jgCH1cbOlOGoHdCA</id>
    <link href="https://mp.weixin.qq.com/s/Q9QiK7jgCH1cbOlOGoHdCA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>44个药品增补挂网，注射剂占比过半！</title>
    <updated>2020-12-07T21:39:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/Z5_61Af_Qh_b2TSi2nLNGw</id>
    <link href="https://mp.weixin.qq.com/s/Z5_61Af_Qh_b2TSi2nLNGw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国谈三年，准入品种由36个暴增至97个背后...</title>
    <updated>2020-12-07T21:39:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/rVt_hXfrXj2qvsHa49caxQ</id>
    <link href="https://mp.weixin.qq.com/s/rVt_hXfrXj2qvsHa49caxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>（2020.12.4）多款注射剂迎过评，首家通过占比超七成！</title>
    <updated>2020-12-04T21:42:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/4Ruq0Op_WE8MdO99OOKQDw</id>
    <link href="https://mp.weixin.qq.com/s/4Ruq0Op_WE8MdO99OOKQDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这些畅销药开始降价，涉及恒瑞、天晴、灵北...</title>
    <updated>2020-12-04T21:42:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/8FdCMAMVt6SsiDNB8TmUtg</id>
    <link href="https://mp.weixin.qq.com/s/8FdCMAMVt6SsiDNB8TmUtg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>16个品种进行调价挂网</title>
    <updated>2020-12-04T21:42:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/zUf6c7wI_jntqoqQ69-0rw</id>
    <link href="https://mp.weixin.qq.com/s/zUf6c7wI_jntqoqQ69-0rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年全国各省（联盟）集采进程汇总</title>
    <updated>2020-12-04T21:42:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-04:/s/vEr_6wCTHKmrN8gQv0By4A</id>
    <link href="https://mp.weixin.qq.com/s/vEr_6wCTHKmrN8gQv0By4A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采品种吹风，五大国产制药巨头并驾齐驱！</title>
    <updated>2020-12-03T21:43:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/w0C9h-Bkf89C0ihNXdWiDQ</id>
    <link href="https://mp.weixin.qq.com/s/w0C9h-Bkf89C0ihNXdWiDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>江苏公开征求集采意见，市占率及降幅是关键</title>
    <updated>2020-12-03T21:43:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/yga_e6yAhCDMc3iTGMVoqQ</id>
    <link href="https://mp.weixin.qq.com/s/yga_e6yAhCDMc3iTGMVoqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>